|
|
|
Company Links |
 |
 |
|
|
|
|
|
|
Major Stock Holders
(Prior To
Offering) |
Name |
|
David A. Donnini |
NA |
NA |
NA |
NA |
NA |
NA |
|
GTCR Funds |
NA |
NA |
NA |
NA |
NA |
NA |
|
Peter C. Mann |
NA |
NA |
NA |
NA |
NA |
NA |
|
TCW/Crescent Funds |
NA |
NA |
NA |
NA |
NA |
NA |
|
Vincent J. Hemmer |
NA |
NA |
NA |
NA |
NA |
NA |
|
|
|
|
|
|
|
|
|
|
Company Strategy |
 |
 |
|
The Company sells well-recognized, brand name over-the-counter drug, household cleaning and personal care products. |
|
|
|
Product/Services Portfolio |
 |
 |
|
The Company’s portfolio of over-the-counter drugs consists of Clear eyes, Murine, Chloraseptic, the Compound W wart removal products, the Little Remedies line of pediatric over-the-counter healthcare products and first aid products such as New-Skin and Dermoplast. Other niche brands in this category include Percogesic and Momentum, Freezone, Mosco and Outgro, Sleep-Eze, Compoz and Heet.
Clear eyes, Murine Tears and Murine Ear Care are leading brands in the over-the-counter personal eye and ear care categories. The 0.5 oz. container of Clear eyes redness relief eye drops is the number one selling product in the eye redness relief category and Clear eyes is the number two brand in that category with 16.9% market share. The ear drop category is composed of products that loosen earwax, treat trapped water (swimmer's ear) and treat ear aches. Murine is the number three ear care brand with 16.8% market share.
Chloraseptic's 6 oz. cherry liquid sore throat spray is the number one selling product in the sore throat liquids/sprays segment. The Chloraseptic brand has an ACV of 95% and is number one in sore throat liquids/sprays with 47.3% market share.
Compound W products are specially designed to provide relief of common and plantar warts and are sold in multiple forms of treatment depending on the consumer's need, including Fast-Acting Liquid, Fast-Acting Gel, One Step Pads for Kids, One Step Pads for Adults and Freeze Off.
Little Noses was first introduced to the market in 1992 and is marketed as a product for the relief of childhood nasal discomfort containing no alcohol, saccharin, artificial flavors or coloring dyes. The Little Noses product line consists of saline nasal spray/drops, decongestant nose drops, a nasal aspirator for the removal of mucous from nasal passages and moisturizing nasal gel.
Little Colds was first introduced to the market in 2001 and is marketed as a product for the relief of childhood cold symptoms containing no alcohol, saccharin, artificial flavors or coloring dyes. The Little Colds product line includes six different products consisting of a multi-symptom cold relief formula, dissolvable sore throat relief strips, sore throat relief Saf-T-Pops, cough relief formula, decongestant formula and a combined decongestant plus cough relief formula.
Little Tummy's was first introduced to the market in 1994 and is marketed as a product for the relief of childhood stomach discomfort containing no alcohol, saccharin, artificial flavors or coloring dyes. The Little Tummy's product line consists of gas relief drops, laxative drops and a nausea relief aid.
|
|
|
Investment Analysis |
 |
 |
|
Net sales increased by $48.4 million, or 249.7% from $19.4 million for the quarter ended June 30, 2003 to $67.8 million for the quarter ended June 30, 2004.
Gross profit increased by $19.3 million or 156.6% from $12.3 million for the quarter ended June 30, 2003 to $31.6 million for the quarter ended June 30, 2004.
General and administrative expenses increased by $2.5 million, or 101.6%, from $2.4 million for the quarter ended June 30, 2003 to $4.9 million for the quarter ended June 30, 2004.
Interest expense, net increased by $8.9 million, or 409%, from $2.2 million in the quarter ended June 30, 2003 to $11.0 million in the quarter ended June 30, 2004.
|
|
|
|
Income Data |
| Year |
Revenues |
Costs |
Oper Income |
Taxes |
Net Income |
EPS |
| 2002
|
46201 |
18699 |
9704 |
311 |
560 |
0.00 |
| 2003
|
76439 |
27475 |
17341 |
3902 |
-14422 |
0.00 |
| 2004
|
69059 |
26254 |
12234 |
1684 |
2393 |
0.00 |
|
|
|
Balance Sheet Data
|
Year |
Cash |
Acct Recv. |
Inventory |
Total Cur Assets |
Total Cur Liability |
PPE |
Total Assets |
LT Debt |
SH Equity |
|
2003 |
3530 |
12663 |
5597 |
23637 |
33098 |
615 |
143910 |
61414 |
44797 |
|
2004 |
3393 |
15391 |
9748 |
30754 |
14545 |
880 |
326622 |
146694 |
126509 |
|
|
|
| Cash
Flow Summary
|
Year |
Net Cash-Ops |
Net Cash-Inv |
Net Cash-Fin |
Net Change |
|
2002 |
3940 |
-4412 |
5526 |
5054 |
|
2003 |
12519 |
-2165 |
-14708 |
-4354 |
|
2004 |
7843 |
-576 |
-8629 |
-1362 |
|
*As of period from Apr. 1, 2003 to Feb.5, 2004
| |
|
| |
|
| |
|
|